It was revealed that the novel covalent CDK7 suppressor THZ1, indicated a powerful anti-ESCC-CSCs effect as reflected by the observation that the spheroid-forming potential of KYSE410 cells was suppressed dramatically after THZ1 treatment (Fig. 1a and Supplementary Fig. 1h). The gene discussed is CDK7; the disease is esophageal squamous cell carcinoma.